Search Results for: Clinical Research career

Editor’s note: BioWatch is a regular feature in Local Tech Wire.NCBIO ran a full-page ad in the Boston Globe promoting North Carolina in early December that cost about $47,000, but resulted in something of a public relations coup. “It came to our attention through various sources,” says Sam Taylor, vice president of NCBIO, which represents the biotech industry here, “that politicians in Massachusetts and some of its major metropolitan areas were making decisions that were draconian and negative for the industry.” Springfield, MA Mayor, Michael Albano, for instance, trimmed $9 million from his city budget by creating a program...

Editor’s note: RTP Beat is a regular feature on Thursdays.Zen-Bio, which sells a cultured human fat cell system to companies seeking drug candidates to treat obesity and diabetes, is going through a growth spurt. The eight-year-old company has just signed a lease for an additional 800 square feet of lab and office space in its existing building. It also plans to increase its staff of by three, or 30 percent, by the end of the year. “The market is good for renters,” says Richard Giersch, chief operating officer of Zen-Bio. “It was a no-brainer.” Last week, the biotech firm...

Saying he is eager to get back in the trenches of the patent wars, Gary Pace has left Hutchison & Mason PLLC in Raleigh to become vice president of corporate development and legal affairs at Gentris Corporation. “H & M is a great firm, but I guess I am more disposed to being an operational attorney,” Pace told Local Tech Wire. “I have a lot of operational experience — prosecuting patents, executing and closing transactions. Gentris is the perfect opportunity for me to combine by expertise in science and law and to help build something. “There is quite a...

Gregory Mossinghoff showed up for his second interview with Inspire Pharmaceuticals back in 1998 carrying a well-thumbed folder of Inspire materials from his first interview the previous year. “It looked used, and he had obviously been thinking about the company,” Inspire’s Chief Executive Officer Christy Shaffer tells Local Tech Wire about Inspire’s recently appointed president who had served as senior vice president and chief business officer. Inspire, which had asked Mossinghoff to interview, offered him the position the following week. He had impressed Shaffer and other company officials the first time he interviewed in 1996, but Inspire lacked the...

DURHAM … Pharmaceutical research company Quintiles Transnational (Nasdaq: QTRN) has replaced two people on its nine-member board of directors. Pamela J. Kirby, Quintiles chief executive officer, and Dr. William L. Roper, dean of the School of Public Health at the University of North Carolina at Chapel Hill, have joined the board. They replace Dr. Eric J. Topol, who has served on the board since 1997, and Jim D. Kever, principal of Voyent Partners LLC, who has served since 1999. Neither Topol nor Kever chose to stand for re-election. “We welcome Bill and Pam to our board of directors and...

Wilmington-based aaiPharma Inc.’s board has named Dr. Philip Tabbiner president and chief operating officer of the company. The company also named David Hurley president of NeoSan, the company’s commercialization business unit, previously headed by Dr. Tabbiner. Dr. Tabbiner is a veteran of the pharmaceutical industry whose career has included executive positions at Bayer Corporation, Chiron Corporation, and DuPont Merck Pharmaceuticals. Dr. Tabbiner assumes direction of several key areas of aaiPharma, including: NeoSan Pharmaceuticals, the Company’s product commercialization business unit; and aaiResearch, the licensing and product development unit of the company. During his tenure as president of NeoSan, Dr. Tabbiner...

Dr. David W. Barry, a pioneer in the war against AIDS and the founder and chief executive of Triangle Pharmaceuticals Inc., died Monday night apparently of a heart attack while on business in California. The news of the 58-year-old Barry’s death stunned the Durham company as well as his extensive network of friends and colleagues in the life sciences industry. “He’s a long-time friend and I am deeply shocked by the news,” said Dr. Dino Dina, chief executive officer of Dynavax Technologies in California. Barry and Dina met in 1983 while conducting HIV research. Barry had served on the...